Navigation Links
Paradoxical Alzheimer's finding may shed new light on memory loss
Date:3/12/2008

March 8, 2008 Do you remember the seventh song that played on your radio on the way to work yesterday? Most of us dont, thanks to a normal forgetting process that is constantly cleaning house culling inconsequential information from our brains. Researchers at the Buck Institute now believe that this normal memory loss is hyper-activated in Alzheimers disease (AD) and that this effect is key to the profound memory loss associated with the incurable neurodegenerative disorder.

Last year, this same group of researchers found that they could completely prevent Alzheimers disease in mice genetically engineered with a human Alzheimers geneMouzheimersby blocking a single site of cleavage of one molecule, called APP for amyloid precursor protein. Normally, this site on APP is attacked by molecular scissors called caspases, but blocking that process prevented the disease. Now they have studied human brain tissue and found that, just as expected, patients suffering from AD clearly show more of this cleavage process than people of the same age who do not have the disease. However, when they extended their studies to much younger people without Alzheimers disease, they were astonished to find an apparent paradox: these younger people displayed as much as ten times the amount of the same cleavage event as the AD patients. The researchers now believe they know why.

The Buck Institute study implicates a biochemical switch associated with that cleavage of APP, causing AD brains to become stuck in the process of breaking memories, and points to AD as a syndrome affecting the plasticity or malleability of the brain. The study, due to be published in the March 7 issue of the Journal of Alzheimers Disease, provides new insight into a molecular event resulting in decreased brain plasticity, a central feature of AD.

Young brains operate like Ferraris shifting between forward and reverse, making and breaking memories with a facility that surpasses that of older brains, which are less plastic, said Dale Bredesen, MD, Buck Institute faculty member and leader of the research group. We believe that in aging brains, AD occurs when the molecular shifting switch gets stuck in the reverse position, throwing the balance of making and breaking memories seriously off kilter.

In previous research, lead author Veronica Galvan, PhD, prevented this cleavage in mice genetically engineered to develop the amyloid plaques and deposits associated with AD. These surprising mice had normal memories and showed no signs of brain shrinkage or nerve cell damage, despite the fact that their brains were loaded with the sticky A-beta plaques that are otherwise associated with Alzheimers disease.

A-beta is produced throughout the brain throughout life; we believe that it is a normal regulator of the synapses, the connections between neurons, said Galvan, who added that AD, like cancer, is a disease in which imbalanced cell signaling plays an important role.

The fact that many people develop A-beta plaques yet show no symptoms of AD tells us that the downstream signaling of A-betanot just A-beta itselfis critical, said Bredesen, and these pathways can be targeted therapeutically. Simply put, we can restore the balance. Continuing research at the Buck Institute focuses on nerve signaling and efforts to disconnect the molecular mechanism that throws memory-making in the reverse direction, as well as understanding mechanisms that support brain cell connections that are crucial to the process of memory making.


'/>"/>

Contact: Kris Rebillot
krebillot@buckinstitute.org
415-209-2080
IOS Press
Source:Eurekalert

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. MHA to Release Findings of Independent Long Term Care Member Study
3. New findings about the brain lead to treatment for eating disturbances
4. New Findings Support Alternatives to Pap Test
5. DNA Findings Reveal Genetic History of Humans
6. New findings on emerging contaminants
7. Research findings may lead to new ways to study and fight diabetes
8. A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at Autism Through the Lifespan Conference February 14-17 in Orlando
9. New findings contradict a prevailing belief about the inner ear
10. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
11. New finding may help explain development of preeclampsia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: